urinary retention
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 20-60 years, cervical cancer stage Ib1-IIa2 (2009 FIGO cervical cancer clinical stage), radical hysterectomy, patients with urinary retention after the removal of the urinary catheter 14-60 days after the operation, and the residual urine measurement is greater than 100ml for two consecutive days; 2. The surgical record confirms that the surgical method is radical hysterectomy; 3. The expected survival period is more than 12 months; 4. Agree to participate in this trial and have signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who have received pelvic radiotherapy in the past; 2. Patients with previous symptoms of urination disorder, urinary incontinence, or abnormal preoperative urodynamic testing; 3. Patients with severe urinary tract infection or vesicovaginal fistula; 4. In the acute phase of other diseases: disturbance of consciousness, body temperature greater than 38°C, unstable vital signs or acute abdomen; 5. Patients with functional impairment of important organs: liver enzymes > 2 times the upper limit of normal, creatinine > 2 times the upper limit of normal, blood amylase > 2 times the upper limit of normal, cardiac function grade 3-4, etc.; 6. Brain disease, abnormal judgment ability; 7. Drug and/or alcohol abuse; 8. Patients with mental illness receiving drug treatment; 9. Participated in other clinical trials within 4 weeks before the start of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| residual urine;urodynamic measurement;urine routine; | — |
Countries
China
Contacts
Obstetrics and Gynecology Hospital Affiliated to Fudan University